RT Journal Article SR Electronic T1 High Intelligence is not a Risk Factor for Mental Health Disorders JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2022.05.26.22275621 DO 10.1101/2022.05.26.22275621 A1 Camille Michèle Williams A1 Hugo Peyre A1 Ghislaine Labouret A1 Judicael Fassaya A1 Adoración Guzmán García A1 Nicolas Gauvrit A1 Franck Ramus YR 2022 UL http://medrxiv.org/content/early/2022/05/26/2022.05.26.22275621.abstract AB Objective Studies reporting that highly intelligent individuals have more mental health disorders often have sampling bias, no or inadequate control group, or insufficient sample size. We addressed these caveats by examining the difference in the prevalence of mental health disorders between individuals with high and average general intelligence (g-factor) in the UK Biobank.Methods Participants with general intelligence (g-factor) scores standardized relative to the same-age UK population, were divided into 2 groups: a high g-factor group (g-factor 2 SD above the UK mean; N=16,137) and an average g-factor group (g-factor within 2 SD of the UK mean; N=236,273). Using self-report questionnaires and medical diagnoses, we examined group differences in prevalence across 32 phenotypes, including mental health disorders, trauma, allergies, and other traits.Results High and average g-factor groups differed across 15/32 phenotypes and did not depend on sex and/or age. Individuals with high g-factors had less general anxiety (OR=0.69) and PTSD (OR=0.67), were less neurotic (β=-0.12), less socially isolated (OR=0.85), and were less likely to have experienced childhood stressors and abuse, adulthood stressors, or catastrophic trauma (OR=0.69-0.90). They did not differ in any other mental health disorder or trait. However, they generally had more allergies (e.g., eczema; OR=1.13-1.33).Conclusions The present study provides robust evidence that highly intelligent individuals have no more mental health disorders than the average population. High intelligence even appears as a protective factor for general anxiety and PTSD.Question Are high IQ individuals at increased risk of mental health disorders?Findings In the UK Biobank (N ≃ 7,266 - 252,249), highly intelligent individuals (2SD above the population mean) were less likely to suffer from general anxiety and PTSD, and no more likely to have depression, social anxiety, a drug use disorder, eating disorders, obsessive-compulsive disorder, bipolar disorder, and schizophrenia.Meaning Contrary to popular belief, high intelligence is not a risk factor for psychiatric disorders and even serves as a protective factor for general anxiety and PTSD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work received support under the program Investissements d Avenir launched by the French Government and implemented by l Agence Nationale de la recherche (ANR) with the references ANR-17-EURE-0017 and ANR-10-IDEX-0001-02 PSL. This research has been conducted using the UK Biobank Resource.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All participants provided informed consent (Resources tab at https://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=200). The UK Biobank received ethical approval from the Research Ethics Committee (reference 11/NW/0382) and the present study was conducted based on application 46 007I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis research has been conducted using data from UK Biobank, a major biomedical database (http://www.ukbiobank.ac.uk/). Restrictions apply to the availability of these data, which were used under license for this study: application 46007. Preregistration and code are available on OSF: https://osf.io/cywd6/?view_only=fa9f5091de124d96be3eb1a55a4e7f01 https://osf.io/cywd6/?view_only=fa9f5091de124d96be3eb1a55a4e7f01